Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2019
Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNAAnna K Blakney, Paul F McKay, Dennis Christensen, et al.
Frontiers in Immunology|January 7, 2016
Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatisEmma Lorenzen, Frank Follmann, Sarah Bøje, et al.
NPJ Vaccines|January 30, 2020
Parenteral vaccination protects against transcervical infection with <i>Chlamydia trachomatis</i> and generate tissue-resident T cells post-challengeNina Dieu Nhien Tran Nguyen, Anja W Olsen, Emma Lorenzen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2015
Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approachFabrice Rose, Jeanette Erbo Wern, Pall Thor Ingvarsson, et al.
The Journal of Infectious Diseases|October 17, 2006
Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infectionAnja Weinreich Olsen, Frank Follmann, Klaus Jensen, et al.
Developmental and Comparative Immunology|January 24, 2016
Characterization of cytological changes, IgA, IgG and IL-8 levels and pH value in the vagina of prepubertal and sexually mature Ellegaard Göttingen minipigs during an estrous cycleEmma Lorenzen, Jørgen Steen Agerholm, Anette Blak Grossi, et al.
International Journal of Molecular Sciences|February 15, 2022
A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus DiseaseJulie Zimmermann, Signe Tandrup Schmidt, Ramona Trebbien, et al.
NPJ Vaccines|April 2, 2025
Post-exposure vaccine protection of CTH522/CAF<sup>®</sup>01 against reinfection with Chlamydia trachomatis requires Th1/Th17 but not Th2-immunityNina Dieu Nhien Tran Nguyen, Sharmila Subratheepam, Safia Guleed, et al.
Nature Communications|February 23, 2024
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in miceAnja W Olsen, Ida Rosenkrands, Christina S Jacobsen, et al.
BMC Veterinary Research|September 12, 2016
Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar DKarin Erneholm, Emma Lorenzen, Sarah Bøje, et al.
Pageof 6